Cancer News and Research

Latest Cancer News and Research

Biovest announces interim blinded data of fast-tracked pivotal phase 3 clinical trial of BiovaxID

Biovest International announced on June 27, 2007 blinded interim data from the start of its fast-tracked pivotal Phase 3 clinical trial of BiovaxID for Non-Hodgkin's lymphoma (NHL) from September 2000 through June 2006.

29 Jun 2007

Multiple-electrode radiofrequency ablation safe and effective way of treating patients with liver cancer

Multiple-electrode radiofrequency ablation is a safe and effective way of treating patients with liver cancer that can be completed in less time than current ablation techniques, according to a recent study conducted by researchers at the University of Wisconsin in Madison.

29 Jun 2007

One in 10 hospice patients are referred too late for services

The study is based on surveys completed by bereaved family members and designed to gauge the quality of hospice programs, which provide medical care with social, emotional and spiritual support for the dying.

29 Jun 2007

How medical homes promote equity in health care

Providing minority patients a medical home in which they have a regular doctor or health professional who oversees and coordinates their care would help eliminate racial and ethnic health disparities and promote more health care equity, says a new report from the Commonwealth Fund.

28 Jun 2007

Support for chromosomal theory of cancer found in cancers' development of drug resistance

Thirty-six years into the war on cancer, scientists have not only failed to come up with a cure, but most of the newer drugs suffer from the same problems as those available in the pre-war days: serious toxicity, limited effectiveness and eventual resistance.

28 Jun 2007

New type of mouse embryonic stem cell discovered

Scientists have discovered a new type of mouse embryonic stem cell that is the closest counterpart yet to human embryonic stem (ES) cells, the National Institutes of Health (NIH) have announced.

28 Jun 2007

Scientists discover role of ataxia telangiectasia mutated protein in DNA repair

Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Cancer Institute (NCI), and Integrative Bioinformatics Inc. have made an important discovery about the role of an enzyme called ataxia telangiectasia mutated protein (ATM) in the body's ability to repair damaged DNA.

28 Jun 2007

Long-term effects of cancer survivorship on the employment of older workers

Cancer survivors between 55 and 65 years old who remain cancer-free for two to six years after diagnosis are as likely to be working as their peers who have not had cancer, a new study shows. However, people recently diagnosed with new cancers are less likely to be working.

28 Jun 2007

Web-based software program helps predict survivability for some cancer patients

Oregon Health & Science University Cancer Institute researchers have developed a Web-based software program that can help head and neck cancer patients better predict their survivability.

28 Jun 2007

New model for signal transduction in cells

Among the key communication systems within a cell is the Wnt signaling pathway, which regulates embryonic development and whose deregulation can also contribute to cancer development.

28 Jun 2007

Polymeric nanoparticles show potential as new method for drug delivery

Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.

28 Jun 2007

Trial shows CERVARIX cervical cancer candidate vaccine effective

Results from an interim analysis of a Phase III study show that CERVARIX, the GlaxoSmithKline (GSK) cervical cancer candidate vaccine, provides up to 100 percent protection against advanced precancerous lesions caused by the most common types of human papillomavirus, types 16 and 18.

28 Jun 2007

New approach for tackling allergies

Allergies, like the common cold and asthma, have basically defied the best efforts of modern medicine to cure them.

28 Jun 2007

Summer's here so look out for Legionnaires disease

Summer's here and the living isn't always so easy especially if youre in the hospital. Patients who are vulnerable to infection run a greater risk of contracting Legionnaires disease, a severe form of pneumonia, during warm, humid weather, according to a study published in the Journal of Infectious Diseases.

28 Jun 2007

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.

28 Jun 2007